The impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy

Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma

(2015) Maria Gkotzamanidou et al.   Clinical Lymphoma Myeloma & Leukemia

Molecular pathogenesis of multiple myeloma: basic and clinical updates

(2013) Marta Chesi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

(2012) S. Kumar et al.   BLOOD

Clonal competition with alternating dominance in multiple myeloma

(2012) J. J. Keats et al.   BLOOD

Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma

(2012) Miki Kiyota et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Molecular pathogenesis of multiple myeloma and its premalignant precursor

(2012) W. Michael Kuehl et al.   JOURNAL OF CLINICAL INVESTIGATION

Successful Treatment of Immunoglobulin D Myeloma by Bortezomib and Dexamethasone Therapy

(2011) Naohiro Sekiguchi et al.   INTERNAL MEDICINE

Update on risk stratification and treatment of newly diagnosed multiple myeloma

(2011) Prashant Kapoor et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

(2011) W-J Chng et al.   LEUKEMIA

Double-hit B-cell lymphomas

(2010) S. M. Aukema et al.   BLOOD

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

(2009) R Fonseca et al.   LEUKEMIA

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

(2009) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

(2008) R A Kyle et al.   LEUKEMIA

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE